SAMN43076142
External Id
China Pharmaceutical University
INSDC center name
2024-08-08T00:00:00Z
INSDC first public
2024-08-09T17:41:35.807Z
INSDC last update
SRS22292278
INSDC secondary accession
live
INSDC status
Model organism or animal
NCBI submission model
Model.organism.animal.1.0
NCBI submission package
SRS22292278
SRA accession
BALB/c
breed
H22
cell_line
2022-10
collection_date
We aimed to predict and screen neoantigens from mouse liver cancer H22 cell line. H22 cells were cultured in a medium of 1640 with 10% FBS in 5% CO2. After collecting enough cells, we used whole exome sequencing (WES) and RNA sequencing to get mutation and expression information of the H22 cell line. For comparison, we also got healthy livers from Balbc female mice (5-6 weeks old) and used WES to get normal exome. By fully analyzing the exome of liver cells, the H22 cell line, and the transcriptome of the H22 cell line, we found the neoantigens in the H22 cell line.
description
plateau
dev_stage
China: Nanjing
geo_loc_name
Mus musculus
http://purl.obolibrary.org/obo/NCBITaxon_10090
organism
not applicable
sex
liver cancer
tissue
WES of H22 cell line from BALB/c mouse
title